Ignite Creation Date:
2025-12-26 @ 11:49 AM
Ignite Modification Date:
2025-12-26 @ 11:49 AM
Study NCT ID:
NCT06092216
Status:
TERMINATED
Last Update Posted:
2025-09-16
First Post:
2023-10-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Spesolimab in Pyoderma Gangrenosum
Sponsor:
Icahn School of Medicine at Mount Sinai
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-09-23
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01-14
Completion Date Type:
ACTUAL
First Submit Date:
2023-10-16
First Submit QC Date:
None
Study First Post Date:
2023-10-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-10
Last Update Post Date:
2025-09-16
Last Update Post Date Type:
ESTIMATED